X

Vous n'êtes pas connecté

  - PHARMABIZ.COM - A la Une - 13/07/2024 00:00

Thermo Fisher Scientific to help advance myeloid cancer clinical research and treatment utilizing NGS technology

To help accelerate research into new treatments for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), Thermo Fisher Scientific Inc., the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the

Articles similaires

Targeting fusion protein’s role in childhood leukaemia produces striking results

oncologynews.com.au - 27/Jun 14:47

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...

Targeting fusion protein’s role in childhood leukaemia produces striking results

oncologynews.com.au - 27/Jun 14:47

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...

Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia

news.medical.net - 26/Jun 14:19

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...

Sorry! Image not available at this time

Servier India introduces 'Ivosidenib' in India, first─in─class targeted therapy in oncology for rare IDH1─mutated AML & CCA

pharmabiz.com - 21/Jun 21:02

Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...

Sorry! Image not available at this time

Servier India introduces 'Ivosidenib' in India, first─in─class targeted therapy in oncology for rare IDH1─mutated AML & CCA

pharmabiz.com - 21/Jun 21:02

Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...

Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies

oncologynews.com.au - 01/Jul 15:19

Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...

Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies

oncologynews.com.au - 01/Jul 15:19

Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...

Sorry! Image not available at this time

What Makes AML So Dangerous? Understanding One Of The Fastest-Growing And Hardest-To-Treat Blood Cancers

zeenews.india.com - 30/Jun 12:20

Acute Myeloid Leukemia (AML) grows at lightning speed and demands urgent, personalised treatment, here’s why early diagnosis is critical.

Sorry! Image not available at this time

What Makes AML So Dangerous? Understanding One Of The Fastest-Growing And Hardest-To-Treat Blood Cancers

zeenews.india.com - 30/Jun 12:20

Acute Myeloid Leukemia (AML) grows at lightning speed and demands urgent, personalised treatment, here’s why early diagnosis is critical.

Sorry! Image not available at this time

Acute Myeloid Leukemia: Expert Explains Why This Aggressive Blood Cancer Is Rising Fast In India

zeenews.india.com - 22/Jun 10:41

AML is a silent but deadly blood cancer that’s claiming Indian lives due to delayed diagnosis and lack of access, here’s what an expert wants you...